MB

Martin Bryant

IP Idenix Pharmaceuticals: 10 patents #14 of 67Top 25%
CN CNRS: 7 patents #218 of 11,908Top 2%
LI L'Universite Montpellier Ii: 6 patents #3 of 12Top 25%
GS G.D. Searle: 5 patents #188 of 659Top 30%
EU Emory University: 2 patents #289 of 1,217Top 25%
MV Medimmune Vaccines: 2 patents #7 of 26Top 30%
ML Medimmune Limited: 1 patents #469 of 738Top 65%
C. C.N.R.S.: 1 patents #27 of 220Top 15%
NA Novartis Ag: 1 patents #2,882 of 5,128Top 60%
UC Università Degli Studi Di Cagliari: 1 patents #17 of 61Top 30%
MT Monsanto Technology: 1 patents #877 of 1,657Top 55%
📍 Franklin, TN: #16 of 577 inventorsTop 3%
🗺 Tennessee: #529 of 20,272 inventorsTop 3%
Overall (All Time): #164,375 of 4,157,543Top 4%
25
Patents All Time

Issued Patents All Time

Showing 1–25 of 25 patents

Patent #TitleCo-InventorsDate
9290533 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Jean-Louis Imbach 2016-03-22
7795238 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Jean-Louis Imbach 2010-09-14
7585851 3′-prodrugs of 2′-deoxy-β-L-nucleosides Gilles Gosselin, Jean-Louis Imbach 2009-09-08
7465574 Recombinant RSV virus expression systems and vaccines Hong Jin, Roderick Tang, Shengqiang Li 2008-12-16
7304043 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Jean-Louis Imbach 2007-12-04
7205013 Recombinant RSV virus expression systems and vaccines Hong Jin, Roderick Tang, Shengqiang Li 2007-04-17
6946450 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Jean-Louis Imbach 2005-09-20
6875751 3′-prodrugs of 2′-deoxy-β-L-nucleosides Jean-Louis Imbach, Gilles Gosselin 2005-04-05
6830748 Recombinant RSV virus expression systems and vaccines Hong Jin, Roderick Tang, Shengqiang Li 2004-12-14
6809083 Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections Richard A. Mueller, Richard A. Partis, Gary S. Jacob, Timothy M. Block, Raymond A. Dwek 2004-10-26
6787526 Methods of treating hepatitis delta virus infection with &bgr;-L-2′-deoxy-nucleosides Jean-Pierre Sommadossi 2004-09-07
6747149 Glucamine salts for treating hepatitis virus infections Richard A. Mueller, Richard A. Partis 2004-06-08
6602664 3′-azido-2′,3′-dideoxyuridine in an anti-HIV effectiveness test protocol Raymond F. Schinazi, Maureen W. Myers 2003-08-05
6596700 Methods of treating hepatitis delta virus infection with &bgr;-L-2'-deoxy-nucleosides Jean-Pierre Sommadossi 2003-07-22
6569837 &bgr;-L-2′-deoxy pyrimidine nucleosides for the treatment of hepatitis B Gilles Gosselin, Jean-Louis Imbach 2003-05-27
6566344 &bgr;-L-2′-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Jean-Louis Imbach 2003-05-20
6545007 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines Jean-Pierre Sommadossi, Marino Artico, Paolo La Colla 2003-04-08
6545021 Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections Richard A. Mueller, Richard A. Partis 2003-04-08
6515028 Glucamine compounds for treating hepatitis virus infections Richard A. Mueller, Richard A. Partis 2003-02-04
6444652 &bgr;-L-2'-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Jean-Louis Imbach 2002-09-03
6395716 &bgr;-L-2′-deoxy-nucleosides for the treatment of hepatitis B Gilles Gosselin, Jean-Louis Imbach 2002-05-28
6194391 3'-azido-2',3'-dideoxyuridine administration to treat HIV and related test protocol Raymond F. Schinazi, Maureen W. Myers 2001-02-27
6100277 Retroviral protease inhibitor combinations Simon Tucker, Karen Potts, Mary Smidt 2000-08-08
6069235 Method for carbohydrate engineering of glycoproteins Simon Davis, Terence D. Butters, Gunilla Karlsson, Frances M. Platt, Raymond A. Dwek 2000-05-30
5622972 Method for treating a mammal infected with respiratory syncytial virus Francis J. Koszyk, Richard A. Mueller, Richard A. Partis 1997-04-22